Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05739136 · ClinicalTrials.gov registry record
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
A clinical trial of Pregnancy Related and Pregnancy Complications, sponsored by Sumitomo Pharma Switzerland.
- Active
- Registry status
- 530
- Enrollment target
- 1
- Study location
NCT05739136 is a study of Pregnancy Related and Pregnancy Complications that is active but no longer recruiting, run by Sumitomo Pharma Switzerland. The registered enrollment target is 530 participants, below the 1,958-participant average among 99 other Pregnancy Related trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05739136, a study of Pregnancy Related and Pregnancy Complications, is active but no longer recruiting, sponsored by Sumitomo Pharma Switzerland.
- ACTIVE NOT RECRUITING
- Registry status
- 530 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective cohort study that will be conducted using secondary de-identified electronic healthcare data (EHD) that originally were collected for the purposes of health insurance billing and/or routine patient care from healthcare providers (HCPs). The study is designed to evaluate the association between relugolix combination therapy (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) exposure during pregnancy and subsequent fetal and infant outcomes.
Conditions Studied
Interventions
- DRUG Relugolix + Estradiol + Norethindrone Acetate
Study Locations (1)
Massachusetts
- SMPA - Marlborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 2025-04-30 |
| Est. Completion | 2027-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05739136
The ClinicalTrials.gov registry entry for NCT05739136 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 530 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,958-participant average among 99 other Pregnancy Related trials with a reported enrollment target (73% lower). The listed sponsor is Sumitomo Pharma Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Relugolix + Estradiol + Norethindrone Acetate is the first listed.
NCT05739136 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05739136 about?
NCT05739136 is a clinical study titled "MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy". This is a retrospective cohort study that will be conducted using secondary de-identified electronic healthcare data (EHD) that originally were collected for the purposes of health insurance billing and/or routine patient care from healthcare providers (HCPs). The study is designed to evaluate the a...
What is the current status of trial NCT05739136?
This trial is currently active not recruiting. The enrollment target is 530 participants. The study started on 2025-04-30. Estimated completion is 2027-05.
What conditions does trial NCT05739136 study?
This clinical trial studies the following conditions: Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk.
What interventions are being tested in trial NCT05739136?
The interventions under investigation include: Relugolix + Estradiol + Norethindrone Acetate (DRUG).
Who is sponsoring clinical trial NCT05739136?
This trial is sponsored by Sumitomo Pharma Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05739136 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.